Heyan Biotech

About:

Heyan Biotech provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services.

Website: https://www.huiyan-bio.com/

Top Investors: Greenriver Investment

Description:

Heyan Biotech is a national biotech industry base, provides for target based in vitro pharmacodynamic screening and early pharmacological pharmacodynamic evaluation services in early drug discovery.

Total Funding Amount:

$1.5M

Headquarters Location:

Wuhan, Hubei, China

Founded Date:

2013-09-01

Contact Email:

huiyanbio(AT)126.com

Founders:

Number of Employees:

Last Funding Date:

2020-11-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai